Company profile: Helix BioMedix
1.1 - Company Overview
Company description
- Provider of skin health consumer products and bioactive peptide solutions for dermatological and personal care, including a proprietary peptide library with antimicrobial, anti-inflammatory and wound healing properties; SmartPeptides to enhance skin appearance; Oligopeptide-10 for acne; Palmitoyl Hexapeptide-14 and Hexapeptide-21 to stimulate collagen; and HB4208, a preclinical DNA Damage Response enzyme for Xeroderma Pigmentosum.
Products and services
- Bioactive Peptide Library: A proprietary collection of peptides delivering antimicrobial, anti-inflammatory, and wound-healing activities, used in dermatological and personal care applications
- SmartPeptides: Peptide-based bioactives engineered to enhance skin health by stimulating cellular processes and improving appearance in cosmeceutical formulations
- Oligopeptide-10: An antimicrobial peptide used in acne products to reduce blemishes and redness by enhancing natural defense systems
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Helix BioMedix
Cubist
HQ: United States
Website
- Description: Provider of biopharmaceutical products focused on the research, development, and commercialization of therapies addressing unmet medical needs in the acute care environment; markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cubist company profile →
LigoCyte Pharmaceuticals
HQ: United States
Website
- Description: Provider of vaccines and monoclonal antibodies for gastrointestinal and respiratory indications, developing novel immunomodulatory drug compounds that modify immune responses by targeting cell binding interactions for the treatment of inflammatory and infectious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LigoCyte Pharmaceuticals company profile →
60 Degrees Pharmaceuticals
HQ: United States
Website
- Description: Provider of medicines to treat and prevent infectious diseases, including ARAKODA (tafenoquine) for malaria prophylaxis in patients 18+, a Dengue Fever Treatment Program developing 60P001 (alpha-glucosidase inhibitor) and 60P002 (platelet-activating factor receptor antagonist), and a Malaria Prevention Program developing new drugs to address limitations of existing prophylactics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 60 Degrees Pharmaceuticals company profile →
Microgen Bioproducts
HQ: United Kingdom
Website
- Description: Provider of diagnostic products for clinical, food, and environmental testing, with a portfolio for clinical laboratories including microbiology diagnostics; engages in the development, manufacture, distribution, and marketing of products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microgen Bioproducts company profile →
Accelerate Diagnostics
HQ: United States
Website
- Description: Provider of in vitro diagnostic solutions for drug-resistant organisms and hospital-acquired infections, offering the Accelerate Pheno System for rapid ID and AST of bloodstream infections from positive blood cultures; the Accelerate Arc System for automated ID directly from positive blood cultures; the Accelerate PhenoTest BC Kit used with the Pheno system for fast ID and susceptibility results; and Gel Electrofiltration for sample cleanup.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accelerate Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Helix BioMedix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Helix BioMedix
2.2 - Growth funds investing in similar companies to Helix BioMedix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Helix BioMedix
4.2 - Public trading comparable groups for Helix BioMedix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →